TrialDiabetes, obesity & metabolism2017

Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study.

Kishore M Gadde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.